Literature DB >> 16107230

Ventilatory strategies in patients with sepsis and respiratory failure.

Dean R Hess1, B Taylor Thompson.   

Abstract

Patients with sepsis may require mechanical ventilation due to the acute respiratory distress syndrome (ARDS). It has become increasingly accepted that mechanical ventilation can contribute to lung injury in these patients. The modern concept of ventilator-induced lung injury is described in the context of alveolar over-distention (volutrauma), alveolar de-recruitment (atelectrauma), and biochemical injury and inflammation to the lung parenchyma (biotrauma). To avoid over-distention lung injury, the tidal volume should be set at 6 mL/kg predicted body weight and plateau pressure should be limited to 30 cm H2O. This has been shown to afford a survival benefit. Although setting positive end-expiratory pressure (PEEP) to zero is likely harmful during mechanical ventilation of patients with ARDS, evidence is lacking for a survival benefit if a high PEEP level is set compared with a modest level of PEEP. Although adjunctive measures such as recruitment maneuvers, prone position, and inhaled nitric oxide may improve oxygenation, evidence is lacking that these measures improve survival.

Entities:  

Year:  2005        PMID: 16107230     DOI: 10.1007/s11908-005-0007-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  44 in total

Review 1.  Treatment of ARDS.

Authors:  R G Brower; L B Ware; Y Berthiaume; M A Matthay
Journal:  Chest       Date:  2001-10       Impact factor: 9.410

2.  Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes.

Authors:  Peter Q Eichacker; Eric P Gerstenberger; Steven M Banks; Xizhong Cui; Charles Natanson
Journal:  Am J Respir Crit Care Med       Date:  2002-08-28       Impact factor: 21.405

3.  Impact of randomized trial results on acute lung injury ventilator therapy in teaching hospitals.

Authors:  Craig R Weinert; Cynthia R Gross; William A Marinelli
Journal:  Am J Respir Crit Care Med       Date:  2003-02-05       Impact factor: 21.405

Review 4.  Other approaches to open-lung ventilation: airway pressure release ventilation.

Authors:  Nader M Habashi
Journal:  Crit Care Med       Date:  2005-03       Impact factor: 7.598

Review 5.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

6.  Effects of recruiting maneuvers in patients with acute respiratory distress syndrome ventilated with protective ventilatory strategy.

Authors:  Salvatore Grasso; Luciana Mascia; Monica Del Turco; Paolo Malacarne; Francesco Giunta; Laurent Brochard; Arthur S Slutsky; V Marco Ranieri
Journal:  Anesthesiology       Date:  2002-04       Impact factor: 7.892

7.  One-year outcomes in survivors of the acute respiratory distress syndrome.

Authors:  Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

Review 8.  Ventilator-induced lung injury: lessons from experimental studies.

Authors:  D Dreyfuss; G Saumon
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 30.528

Review 9.  Reinterpreting the pressure-volume curve in patients with acute respiratory distress syndrome.

Authors:  Keith G Hickling
Journal:  Curr Opin Crit Care       Date:  2002-02       Impact factor: 3.687

10.  Clinical risks for development of the acute respiratory distress syndrome.

Authors:  L D Hudson; J A Milberg; D Anardi; R J Maunder
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.